This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) inched 0.89% higher to $108.41 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.37% to 4,536.19 and the Dow Jones Industrial Average rising 0.43% to 35,609.34. This was the stock's second consecutive day of gains. AbbVie Inc. closed $13.12 below its 52-week high ($121.53), which the company achieved on September 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Pfizer Inc. (PFE) rose 1.69% to $42.80, Eli Lilly & Co. (LLY) rose 0.58% to $243.72, and AstraZeneca PLC ADR (AZN.LN) rose 0.76% to $60.63. Trading volume (5.6 M) remained 1.9 million below its 50-day average volume of 7.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 20, 2021.
(END) Dow Jones Newswires
October 20, 2021 16:33 ET (20:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.